Work

425P: Real-world data of everolimus in patients with thymic epithelial tumors (TETs)

Year: 2025

Type: article

Source: Journal of Thoracic Oncology

DOI: 10.1016/s1556-0864(25)00617-3

Authors: Á. López Gutiérrez, J.D. Florez Arango, J.C. Benitez Montanez, D. Miliziano, E. Dansin, G. Giaccone, C. Basse, J. Mazieres, T. Pierret, E. Pons-Tostivint, J. Arrondeau, M. Aldea, D. Diaz Jiménez, L. Zullo, F. Aboubakar, P. Missy, J. Remon Masip, T. Molina, N. Girard, B. Besse

Institutions: Institut Gustave Roussy, Instituto de Cancerología Las Américas, Hospital Clínico Universitario Virgen de la Victoria, Centre Oscar Lambret, NewYork–Presbyterian Hospital, Weill Cornell Medicine, Institut Curie, Centre Hospitalier Universitaire de Toulouse, Hôpital Larrey, Hospices Civils de Lyon, Hôpital Louis Pradel, Centre Hospitalier Universitaire de Nantes, Hôpital Cochin, Assistance Publique – Hôpitaux de Paris, Cliniques Universitaires Saint-Luc, UCLouvain, Intergroupe Francophone de Cancérologie Thoracique, Hôpital Necker-Enfants Malades

Language: English

Topic: Myasthenia Gravis and Thymoma

Subfield: Clinical Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: AstraZeneca, Javna Agencija za Raziskovalno Dejavnost RS, Univerza v Ljubljani, Institut Gustave-Roussy

Awards: Pharmaceutical technology: from drug delivery systems to therapeutic outcomes of medicines in children end elderly, Slovenian network of allergy and asthma: from epidemiology to genetics

OpenAlex ID: W4408996402

FWCI: 0.498

Cites:

Cited by: 1

Related to: 10